The long-term safety of breast implants; a topic widely thought to have been resolved over the decades, is receiving renewed interest from medical communities around the world and is now on the radar of the U.S. Food and Drug Administration. What started as concern over a type of cancer predominantly tied to textured breast implants has led to new questions being ...
Breast Implant Safety Draws Renewed Federal Attention
Posted April 2, 2019 in Drug and Medical Device Lawsuits | Product News and Recalls
Textured Breast Implants Officially Off the European Market
Posted January 31, 2019 in Product News and Recalls
French health regulators have officially suspended their approval of the use of textured breast implants. The move means that the implants, which differ from the smooth-surfaced implants more widely used throughout the United States, are effectively no longer available anywhere in Europe.
Textured breast implants have been implicated as a possible cause of a specific type of lymphoma. The disease, formally known as breast implant-associated anaplastic large-cell lymphoma, ...
continue reading...
